Mario Plaas
Grants and prizes
Personal research funding: Team grant (PRG), A New Frontier in Wolfram Syndrome Research: Unraveling Pathophysiology and Pioneering Targeted Therapies, PRG3114, 2026–2030, 1 Jan 2026
Personal research funding: Start-up grant (PSG), GLP1 receptor agonist Liraglutide and NRF2 activator RTA-408 therapy to relieve neurodegenerative symptoms in rat model of Wolfram syndrome, PSG471, 2020–2024, 1 Jan 2020
Sources: openalex.org